Skip to main content
. 2019 Sep 3;12:333–341. doi: 10.2147/IJGM.S219744

Table 3.

Molecular response of the study subjects

Response targets Yes, n (%) No, n (%)
High-NRBC Low-NRBC High-NRBC Low-NRBC
BCR-ABL≤10% at T6 (n=71) 2 (2.8) 42 (59.2) 8 (11.3) 19 (26.7)
BCR-ABL≤1% at T12 (n=59) 3 (5.0) 27 (45.8) 10 (17.0) 19 (32.2)
BCR-ABL≤0.1% at T18 (n=58) 2 (3.5) 22 (37.9) 12 (20.7) 22 (37.9)

Notes: High-NRBC: NRBC≥0.003×109/L; Low-NRBC: NRBC<0.003×109/L.

Abbreviations: T6, after 6 months of treatment; T12, after 12 months of treatment; T18, after 18 months of treatment.